 |
IOPtima
Last updated: July 29, 2024
Ronen Castro, CEO
Israel | Funding: $7.2M (+)
Website: http://www.ioptima.co.il
IOPtima develops minimally-invasive surgical ophthalmic devices. The company’s flagship product IOPtimate is a surgical system for the treatment of Glaucoma, which utilizes a CO2 laser technology to significantly reduce internal eye pressure (“IOP”), by restoring the natural fluid percolation without penetrating into the eye.
Website: http://www.ioptima.co.il
IOPtima develops minimally-invasive surgical ophthalmic devices. The company’s flagship product IOPtimate is a surgical system for the treatment of Glaucoma, which utilizes a CO2 laser technology to significantly reduce internal eye pressure (“IOP”), by restoring the natural fluid percolation without penetrating into the eye.
